DELTALITSIN
UkraineThe drug is used to treat disorders caused by stress (irritability, emotional disturbances, sleep problems, anxiety, decreased memory, and reduced work capacity). It is also used in narcology to eliminate alcohol withdrawal syndrome and alcohol cravings, as well as in cases of alcohol and drug intoxication.
Frequently asked questions
How should Deltalitsin be taken correctly?
The powder must be dissolved immediately before use by adding 10–12 drops of distilled or boiled water at room temperature. Administer 1–2 drops into each nostril at intervals of 15–20 minutes. When administering to the left nostril, the head should be tilted toward the right shoulder, and vice versa. It is important that the drug does not enter the nasopharynx.
What is the dosage for adults?
Depending on the severity of the condition, adults may use 1 to 3 ampoules or vials per day for 5–10 days. If necessary, the course can be repeated after 4–8 weeks.
Are there any contraindications for use?
The main contraindication is hypersensitivity to the components of the drug.
What are the possible side effects of Deltalitsin?
Allergic reactions are possible.
Can you drive a car during treatment?
While taking the drug, caution should be exercised when driving motor vehicles or operating other mechanisms that require increased attention.
Instructions for use
INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT DELTALICIN (DELTALICIN)
Composition:
Active substance: 1 ampoule or vial contains 0.3 mg of delta-sleep peptide (0.0003 g);
Excipient: glycine.
Pharmaceutical form. Lyophilized powder for preparation of nasal drops.
Main physicochemical properties: white powder or porous mass.
Pharmacotherapeutic group. Medicinal products. ATC code V03A.
Pharmacological Properties
Pharmacodynamics. The delta-sleep peptide, as the main active component of Deltalysin, is a natural neuromodulatory peptide produced in the body and possesses broad pharmacological activity. This peptide exhibits pronounced anti-stress and adaptogenic effects, increasing the body's resistance to various adverse stress factors under pathological conditions caused by diseases of different etiologies. The delta-sleep peptide prevents the development or limits the severity of stress-induced pathological processes; its modulating effect is not manifested under normal physiological conditions. The delta-sleep peptide has antidepressant and anticonvulsant properties, normalizes sleep, demonstrates antitoxic effects, enhances mental and physical performance, and reduces vegetative disorders. This neuropeptide increases electrical stability of the heart and raises the fibrillation threshold, thereby limiting cardiovascular disturbances during stress. The delta-sleep peptide reduces the primary pathological craving for alcohol and alleviates symptoms of alcohol withdrawal.
Pharmacokinetics. Not studied.
Clinical characteristics.
Indications.
Symptomatic treatment of stress-induced disorders associated with irritability, emotional imbalance, dysphoria, and sleep disturbances; symptoms of stress tension (feeling of anxiety, impaired memory, reduced mental performance).
In narcological practice, as a remedy for alleviation of alcohol withdrawal syndrome and primary pathological craving for alcohol. The drug is most effective when vegetative and affective manifestations (subdepressive and dysphoric) are present in the structure of alcohol withdrawal syndrome.
In intoxications: alcohol- and drug-induced.
Contraindications.
Hypersensitivity to the components of the medicinal product.
Interaction with other medicinal products and other types of interactions.
Not established.
Special precautions.
The recommended doses should be strictly followed.
Use during pregnancy or breastfeeding.
There is no experience with the use of the drug during pregnancy or breastfeeding.
Ability to affect reaction speed when driving or operating machinery.
Caution is required when driving or operating machinery during treatment with this medicinal product, as it may affect the ability to react quickly due to increased attention demands.
Method of Administration and Dosage
Administer intranasally (nasal drops). Open the ampoule or vial immediately before use, add 10–12 drops of distilled or boiled water cooled to room temperature, and instill 1–2 drops into the middle part of each nasal passage at 15–20 minute intervals (when instilling the medication into the left nasal passage, tilt the head toward the right shoulder, and vice versa). The preparation is completely absorbed by the nasal mucosa.
Avoid contact of the medication with the nasopharynx.
Depending on the severity of the disease, adults should use 1–3 ampoules or vials per day for 5–10 days. The treatment course may be repeated if necessary after 4–8 weeks.
Children.
There is no experience with use in children.
Overdose.
Not observed.
Side effects.
Allergic reactions are possible.
Shelf life.
2 years.
Storage conditions.
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging.
Lyophilized powder for preparation of nasal drops, 0.0003 g.
5 vials or ampoules per blister; 1 or 2 blisters per package, supplied with a dosing pipette.
Prescription status.
By prescription only.
Manufacturer: LLC "FZ "BIOPHARMA"
Manufacturer's address:
37, Kyivska Street, Bila Tserkva, Kyiv region, 09100, Ukraine.
The original data is available in the language of the country of manufacture.
Data source: State Register of Medicinal Products of Ukraine
Data last verified: August 13, 2026